Ambev S.A. $ABEV Shares Acquired by Privium Fund Management B.V.

Privium Fund Management B.V. grew its position in Ambev S.A. (NYSE:ABEV) by 18.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,063,174 shares of the company’s stock after acquiring an additional 166,040 shares during the period. Ambev comprises approximately 0.5% of Privium Fund Management B.V.’s investment portfolio, making the stock its 29th biggest position. Privium Fund Management B.V.’s holdings in Ambev were worth $2,626,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the company. Massachusetts Financial Services Co. MA raised its position in shares of Ambev by 12.0% in the third quarter. Massachusetts Financial Services Co. MA now owns 36,058,376 shares of the company’s stock worth $80,410,000 after acquiring an additional 3,864,844 shares during the period. Bank of America Corp DE raised its position in shares of Ambev by 9.9% during the 2nd quarter. Bank of America Corp DE now owns 27,505,192 shares of the company’s stock worth $66,288,000 after purchasing an additional 2,479,310 shares during the last quarter. CANADA LIFE ASSURANCE Co raised its position in shares of Ambev by 74.8% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 13,409,316 shares of the company’s stock worth $32,624,000 after purchasing an additional 5,740,155 shares during the last quarter. Kiltearn Partners LLP raised its position in shares of Ambev by 5.6% during the 3rd quarter. Kiltearn Partners LLP now owns 11,045,700 shares of the company’s stock worth $24,632,000 after purchasing an additional 590,000 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Ambev by 14.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 9,521,292 shares of the company’s stock worth $21,249,000 after purchasing an additional 1,178,503 shares during the last quarter. Institutional investors and hedge funds own 8.13% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on ABEV shares. UBS Group set a $2.65 price target on shares of Ambev and gave the stock a “sell” rating in a research report on Thursday, April 16th. Weiss Ratings upgraded shares of Ambev from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, March 5th. Barclays upped their price target on shares of Ambev from $2.50 to $3.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 17th. Finally, Wall Street Zen downgraded shares of Ambev from a “buy” rating to a “hold” rating in a research report on Monday, March 30th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Ambev has an average rating of “Hold” and an average price target of $2.84.

Ambev Stock Up 16.4%

ABEV opened at $3.38 on Wednesday. Ambev S.A. has a twelve month low of $2.10 and a twelve month high of $3.42. The company has a quick ratio of 0.73, a current ratio of 0.96 and a debt-to-equity ratio of 0.03. The company has a 50-day moving average price of $2.98 and a 200 day moving average price of $2.72. The company has a market cap of $53.20 billion, a PE ratio of 18.75, a price-to-earnings-growth ratio of 2.08 and a beta of 0.61.

Ambev (NYSE:ABEV) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.01. The company had revenue of $4.32 billion during the quarter, compared to analysts’ expectations of $4.38 billion. Ambev had a net margin of 17.75% and a return on equity of 16.41%. Sell-side analysts expect that Ambev S.A. will post 0.19 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Ambev news, insider De Lacerda Eduardo Cavalcanti sold 152,386 shares of the stock in a transaction dated Friday, March 27th. The shares were sold at an average price of $2.85, for a total value of $434,300.10. Following the completion of the sale, the insider owned 223,340 shares in the company, valued at approximately $636,519. This represents a 40.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Ambev News Summary

Here are the key news stories impacting Ambev this week:

• Positive Sentiment: Q1 results showed margin expansion and stronger cash flow even with flat consolidated volumes — management highlighted improved profitability and cost discipline that support earnings quality. Ambev Delivers Strong Q1 2026 Results With Higher Margins And Cash Flow
• Positive Sentiment: Board approved new interest‑on‑capital (IOC) payouts and set a July payment for a 2025 tranche; the board also reshuffled committees and executive lineup — actions that increase near‑term cash returns to shareholders and clarify governance. Ambev Reshapes Board Committees, Executive Lineup and Confirms New IOC Payouts
• Neutral Sentiment: Earnings call transcript is available — management commentary confirmed the quarter’s themes (flat volumes, mix improvements, cost control) and offered operational color but no major guidance shifts. Investors can review details for forward outlook clues. Ambev S.A. (ABEV) Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Company filed a routine Form 6‑K with the SEC on May 5 — standard disclosure of results and corporate decisions; no surprise regulatory items flagged. Ambev Files Routine Form 6-K with SEC on May 5, 2026
• Neutral Sentiment: Reviewed interim consolidated financial statements for Q1 were published — useful for detail but largely consistent with the earnings release. Ambev Releases Reviewed Q1 2026 Interim Consolidated Financial Statements
• Negative Sentiment: Revenue slightly missed consensus (reported ~$4.32B vs. ~$4.36B expected) — a modest top‑line shortfall that could cap upside if sustained, though EPS met estimates due to margin gains. Ambev Q1 2026 Press Release / Slide Deck

Ambev Company Profile

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.